Home > Qtrly Results > JENBURKT PHARMACEUTICALS

JENBURKT PHARMACEUTICALS
Quarterly Results Analysis [Mar2026]

JENBURKT PHARMACEUTICALS is part of below Screeners ↓
Best Quarterly Growth Small Cap Stocks
Best 1M Momentum Small Cap Stocks
COMMUNITY POLL
for JENBURKT PHARMACEUTICALS
Please provide your vote to see the results

JENBURKT PHARMACEUTICALS Quarterly Results

Standalone Mar2026
UnAudited
Dec2025
UnAudited
Sep2025
UnAudited
Jun2025
UnAudited
Mar2025
UnAudited
Dec2024
UnAudited
Sep2024
UnAudited
Jun2024
UnAudited
Revenues ₹45 Cr ₹43 Cr ₹46 Cr ₹36 Cr ₹41 Cr ₹37 Cr ₹41 Cr ₹33 Cr
Expenses ₹30 Cr ₹36 Cr ₹32 Cr ₹27 Cr ₹30 Cr ₹28 Cr ₹30 Cr ₹23 Cr
Operating Income ₹14 Cr ₹7 Cr ₹13 Cr ₹9 Cr ₹11 Cr ₹9 Cr ₹11 Cr ₹9 Cr
Other Income ₹4 Cr ₹2 Cr ₹2 Cr ₹2 Cr ₹2 Cr ₹2 Cr ₹2 Cr ₹1 Cr
Interest ₹0 Cr ₹0 Cr ₹0 Cr ₹0 Cr ₹0 Cr ₹0 Cr ₹0 Cr ₹0 Cr
Depreciation ₹1 Cr ₹1 Cr ₹1 Cr ₹1 Cr ₹1 Cr ₹1 Cr ₹1 Cr ₹1 Cr
Profit Before Tax ₹14 Cr ₹8 Cr ₹14 Cr ₹10 Cr ₹12 Cr ₹10 Cr ₹13 Cr ₹10 Cr
Profit After Tax ₹11 Cr ₹6 Cr ₹10 Cr ₹8 Cr ₹9 Cr ₹7 Cr ₹10 Cr ₹7 Cr
EPS ₹24.59 ₹13.44 ₹23.03 ₹17.66 ₹19.34 ₹14.75 ₹21.76 ₹16.80
Industry Peers & Returns1W1M1Y
JENBURKT PHARMACEUTICALS -2.4% 9.2% 4.2%
SUN PHARMACEUTICAL INDUSTRIES -3.2% 10.5% 9.3%
DIVIS LABORATORIES 0.8% 9.5% 4.2%
TORRENT PHARMACEUTICALS 2% 9.9% 35.4%
CIPLA -1.9% 13.3% -6%
DR REDDYS LABORATORIES -1.8% 7.4% 8.2%
MANKIND PHARMA -0.6% 11% -1.8%
LUPIN 1.2% -1.2% 12.7%
ZYDUS LIFESCIENCES 4.8% 11.8% 13.7%

JENBURKT PHARMACEUTICALS Quarterly Revenues

Revenues
Q-o-Q

3.74 %

Y-o-Y

8.73 %

Quarters Revenues % Change
Mar2026 ₹45 Cr
3.74
Dec2025 ₹43 Cr
-5.56
Sep2025 ₹46 Cr
28.23
Jun2025 ₹36 Cr
-13.45
Mar2025 ₹41 Cr
11.26
Dec2024 ₹37 Cr
-10.49
Sep2024 ₹41 Cr
26.68
Jun2024 ₹33 Cr -

JENBURKT PHARMACEUTICALS Quarterly Operating Profit

Operating Profit
Q-o-Q

91.78 %

Y-o-Y

31.24 %

Quarters Operating Profit % Change
Mar2026 ₹14 Cr
91.78
Dec2025 ₹7 Cr
-43.30
Sep2025 ₹13 Cr
46.28
Jun2025 ₹9 Cr
-17.49
Mar2025 ₹11 Cr
23.08
Dec2024 ₹9 Cr
-22.80
Sep2024 ₹11 Cr
23.01
Jun2024 ₹9 Cr -
Operating Margins
Q-o-Q

84.89 %

Y-o-Y

20.72 %

Quarters Operating Margin% % Change
Mar2026 31.93%
84.89
Dec2025 17.27%
-39.95
Sep2025 28.76%
14.08
Jun2025 25.21%
-4.69
Mar2025 26.45%
10.62
Dec2024 23.91%
-13.74
Sep2024 27.72%
-2.91
Jun2024 28.55% -

JENBURKT PHARMACEUTICALS Quarterly Profit After Tax

Profit After Tax(PAT)
Q-o-Q

82.94 %

Y-o-Y

27.11 %

Quarters Profit After Tax % Change
Mar2026 ₹11 Cr
82.94
Dec2025 ₹6 Cr
-41.64
Sep2025 ₹10 Cr
30.41
Jun2025 ₹8 Cr
-8.70
Mar2025 ₹9 Cr
31.16
Dec2024 ₹7 Cr
-32.22
Sep2024 ₹10 Cr
29.49
Jun2024 ₹7 Cr -
PAT Margins
Q-o-Q

76.29 %

Y-o-Y

16.88 %

Quarters PAT Margin(%) % Change
Mar2026 24.31 %
76.29
Dec2025 13.79 %
-38.19
Sep2025 22.31 %
1.69
Jun2025 21.94 %
5.48
Mar2025 20.8 %
17.91
Dec2024 17.64 %
-24.29
Sep2024 23.3 %
2.24
Jun2024 22.79 % -

JENBURKT PHARMACEUTICALS Quarterly Earnings Per Share (EPS)

EPS
Q-o-Q

82.96 %

Y-o-Y

27.15 %

Quarters EPS % Change
Mar2026 ₹24.59
82.96
Dec2025 ₹13.44
-41.64
Sep2025 ₹23.03
30.41
Jun2025 ₹17.66
-8.69
Mar2025 ₹19.34
31.12
Dec2024 ₹14.75
-32.22
Sep2024 ₹21.76
29.52
Jun2024 ₹16.8 -

You may also like the below Video Courses